|
Model Number UNKNOWN |
Device Problem
Insufficient Information (3190)
|
Patient Problems
Host-Tissue Reaction (1297); Stroke/CVA (1770); Death (1802); Endocarditis (1834); Hemorrhage/Bleeding (1888); Thrombus (2101); Regurgitation (2259); Hemolytic Anemia (2279); Thromboembolism (2654)
|
Event Date 11/18/2013 |
Event Type
Death
|
Manufacturer Narrative
|
Requests for additional information provided no further details.Conclusion: no device was returned and no unique device identifier numbers were provided.Based on the available information a review of the device history record could not be performed and root cause could not be identified.
|
|
Event Description
|
Medtronic received information that a study was performed to retrospectively analyze the 20-year clinical results of patients implanted with a medtronic open pivot mechanical heart valve between may 1992 and december 2011 at one institution.The study population included 1,382 patients (predominantly male; mean age 61 years), implanted with a total of 1,520 valves (model/serial not reported)in four cardiac positions: 1,012 aortic, 473 mitral, 26 tricuspid, 9 pulmonary.The 99% complete follow-up totaled 10,527 patient-years (range 12 to 244 months).Across all patients, a total of 550 deaths occurred, including 73 early deaths (within 90 days of implant) and 477 late deaths (more than 90 days following implant).Of early deaths, 8 were considered valve-related: stroke (n=2), bleeding (n=2), valve thrombosis (n=1), hemolysis (n=1), endocarditis (n=1), and sudden death (n=1).Of late deaths, 49 were considered valve-related: sudden death (n=20), anticoagulation-related hemorrhage (n=14), endocarditis (n=7), thromboembolism (n=5), and valve thrombosis (n=3).Other non-death adverse events included: thromboembolism (n=126), major bleeding (n=106), paravalvular leakage (n=32), valve thrombosis (n=29), and endocarditis (n=22).Fifty patients were reoperated due to valve-related issues: paravalvular leakage (n = 20), endocarditis (n = 15), valve thrombosis (n = 14), and pannus formation (n = 2).No additional adverse patient effects were reported.The article concluded the 20-year experience demonstrated excellent clinical outcomes with no structural valve failure.
|
|
Manufacturer Narrative
|
The devices were not returned to medtronic.B)(4).Title: twenty-year single-center experience with the medtronic open pivot mechanical heart valve authors: guido j.Van nooten, md, phd, thierry bov_e, md, yves van belleghem, md, katrien franc¸ois, md, phd, frank caes, md, guy va ndenplas, md, michel de pauw, md, and yves taeymans, md, phd citation: the annals of thoracic surgery, v.97, 4:1306¿13 (doi: http://dx.Doi.Org/10.1016/j.Athoracsur.2013.11.035) event date unknown.
|
|
Manufacturer Narrative
|
A good faith effort will be made to obtain the applicable information relevant to the report.If information is provided in the future, a supplemental report will be issued.
|
|
Search Alerts/Recalls
|
|
|